When Dr. Christopher Hamad started looking into bone health among adults with type 2 diabetes, he needed data from a huge group of patients. Fractures, it turns out, are relatively uncommon, which makes them hard to study unless you have a massive pool of people to draw from. So Hamad and his team at UCLA Health looked at the electronic health records of nearly 134,000 U.S. adults between ages 50 and 90 with type 2 diabetes, tracking them over three years. What they found surprised them: patients taking GLP-1 medications had a 21% lower risk of serious bone breaks compared to patients taking another common diabetes drug.
Fragility fractures are breaks that happen from low-energy trauma, like falling from standing height. They often signal that bones have become weak over time, and people with type 2 diabetes face a higher risk of these fractures than the general population. There had been some concern that GLP-1 drugs, which help people lose significant amounts of weight, might actually make bones weaker by stripping away fat too quickly. But this large study suggests the opposite may be true.
The biggest reductions in fracture risk appeared in the hip, femur, and spine, areas where broken bones can be especially devastating for older adults. A recovery from a broken hip, for example, often means months of rehabilitation and can permanently change a person's independence. The researchers also found that the lower fracture risk was specifically tied to patients who had type 2 diabetes, compared to a matching group of patients without the condition, suggesting the benefit is particularly meaningful for this population.
Hamad noted that most previous studies on GLP-1s and bones were too small or not designed to answer this specific question. Having data from more than 133,000 patients gave his team a much clearer picture of what might actually be happening. The study, published in the journal JAMA Network Open, is observational, meaning it shows a connection between GLP-1 use and fewer fractures but cannot prove the drugs directly cause stronger bones. The researchers say more studies are needed to understand exactly how these medications might be protecting bones over the long term.
Still, for the millions of adults taking GLP-1 medications for diabetes or weight loss, the findings offer a reason for cautious optimism. As research continues, doctors may eventually have another tool for keeping their patients mobile and independent well into their later years.